Laurent Schwartz (oncologist)

Biorébus

In 2004 Schwartz joined with others to start Biorébus, which is a pharmaceutical company, engaged in cancer research. It has focused on the hypotheses that cancer is a metabolic disease akin to diabetes, that inflammation is synonymous to increased osmolarity, and that the toxicity of tobacco is a direct consequence of carbon dioxide poisoning.

Its continuing goals are to determine whether a combined metabolic therapy (Metabloc) can alleviate tumor growth in humans, to understand the link between cancer in the elderly and Alzheimer's disease, and to write in mathematical terms the similarities between biology and cellular electrical forces.